Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application?
de Lemos
James A
JA
Morrow
David A
DA
D000208:Acute Disease; D015415:Biomarkers / Q000097:blood; D015331:Cohort Studies; D003324:Coronary Artery Disease / Q000097:blood* / Q000188:drug therapy; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy; D006801:Humans; D045283:Natriuretic Agents / Q000097:blood* / Q000627:therapeutic use; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D010865:Pilot Projects; D011237:Predictive Value of Tests; D011994:Recombinant Proteins / Q000097:blood / Q000627:therapeutic use
D015415:Biomarkers; D045283:Natriuretic Agents; D009419:Nerve Tissue Proteins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain